Skip to main content Accessibility help

Economic evaluation of mindfulness group therapy for patients with depression, anxiety, stress and adjustment disorders compared with treatment as usual

  • Sanjib Saha (a1), Johan Jarl (a2), Ulf-G Gerdtham (a3), Kristina Sundquist (a4) and Jan Sundquist (a4)...



A randomised controlled trial found that a structured mindfulness group therapy (MGT) programme was as effective as treatment as usual (mostly cognitive–behavioural therapy) for patients with a diagnosis of depression, anxiety or stress and adjustment disorders in Sweden ( NCT01476371).


To perform a cost-effectiveness analysis of MGT compared with treatment as usual from both a healthcare and a societal perspective for the trial duration (8 weeks).


The costs from a healthcare perspective included treatment as usual, medication and costs for providing MGT. The societal perspective included costs from the healthcare perspective plus savings from productivity gains for the trial duration. The effectiveness was measured as quality-adjusted life-years (QALY) using the EQ-5D-5L questionnaire and the UK value set. Uncertainty surrounding the incremental costs and effects were estimated using non-parametric bootstrapping with 5000 replications and presented with 95% confidence intervals and cost-effectiveness acceptability curves.


The MGT group had significantly lower healthcare and societal costs (mean differences –€115 (95% CI −193 to −36) and –€112 (95% CI −207 to −17), respectively) compared with the control group. In terms of effectiveness, there was no significant difference in QALY gain (mean difference −0.003, 95% CI −0.0076 to 0.0012) between the two groups.


MGT is a cost-saving alternative to treatment as usual over the trial duration from both a healthcare and a societal perspective for patients with a diagnosis of depression, anxiety or stress and adjustment disorders in Sweden.

Declaration of interest



Corresponding author

Correspondence: Sanjib Saha, Health Economics Unit, Department of Clinical Sciences (Malmö), Lund University, Medicon village, Scheelevägen 2, SE-22381, Lund, Sweden. Email:


Hide All
1Socialstyrelsen. Nationell utvärdering 2013 – Vård och Insatser vid Depression, Ångest och Schizofreni Rekommendationer, Bedömningar och Sammanfattning [The National Board of Health and Welfare. National evaluation, 2013 – care and interventions for depression, anxiety and schizophrenia, recommendations, estimates and summary]. Socialstyrelsen, 2013.
2Morgan, D. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse. Psychother Res 2003; 13: 123–5.
3Sundquist, J, Lilja, A, Palmer, K, Memon, AA, Wang, X, Johansson, LM, et al. Mindfulness group therapy in primary care patients with depression, anxiety and stress and adjustment disorders: randomised controlled trial. Br J Psychiatry 2015; 206: 128–35.
4Sundquist, J, Palmer, K, Johansson, LM, Sundquist, K. The effect of mindfulness group therapy on a broad range of psychiatric symptoms: a randomised controlled trial in primary health care. Eur Psychiatry 2017; 43: 1927.
5Kuyken, W, Hayes, R, Barrett, B, Byng, R, Dalgleish, T, Kessler, D, et al. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study). Health Technol Assess 2015; 19: 1124.
6Morriss, R, Garland, A, Nixon, N, Guo, B, James, M, Kaylor-Hughes, C, et al. Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trial. Lancet Psychiatry 2016; 3: 821–31.
7Shawyer, F, Enticott, JC, Ozmen, M, Inder, B, Meadows, GN. Mindfulness-based cognitive therapy for recurrent major depression: a ‘best buy’ for health care? Aust N Z J Psychiatry 2016; 50: 1001–13.
8Kabat-Zinn, J, Lipworth, L, Burncy, R, Sellers, W. Four-year follow-up of a meditation-based program for the self-regulation of chronic pain: treatment outcomes and compliance. Clin J Pain 1986; 2: 159774.
9Kabat-Zinn, J, Massion, AO, Kristeller, J, Peterson, LG, Fletcher, KE, Pbert, L, et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry 1992; 149: 936–43.
10Herdman, M, Gudex, C, Lloyd, A, Janssen, M, Kind, P, Parkin, D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20(10): 1727–36.
11Devlin, NJ, Shah, KK, Feng, Y, Mulhern, B, van Hout, B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2018; 27: 722.
12Manca, A, Hawkins, N, Sculpher, MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005; 14: 487–96.
13Drummond, MF, Sculpher, MJ, Torrance, GW, O'Brien, BJ, Stoddart, GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, 2005.
14Swedish Association of Local Authorities and Regions. Cost per person - database for specialized care. Swedish Association of Local Authorities and Regions, no date (
15Sveriges Riskbank. Exchange Rate. Sveriges Riskbank, no date (
16Weisbrod, BA. The valuation of human capital. J Polit Econ 1961; 69: 425–36.
17The Swedish National Mediation Office. Genomsnittslöner 2012. The Swedish National Mediation Office, 2012 (
18Briggs, AH, Wonderling, DE, Mooney, CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997; 6: 327–40.
19Efron, B, Tibshirani, RJ. An Introduction to the Bootstrap. CRC Press, 1994.
20Briggs, A, Fenn, P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998; 7: 723–40.
21Fenwick, E, O'Brien, BJ, Briggs, A. Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. Health Econ 2004; 13: 405–15.
22National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal. NICE, 2004.
23Husereau, D, Drummond, M, Petrou, S, Carswell, C, Moher, D, Greenberg, D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Br Med J 2013; 346; f1049.
24Lavori, PW, Dawson, R, Shera, D. A multiple imputation strategy for clinical trials with truncation of patient data. Statist Med 1995; 14: 1913–25.
25Rubin, D. Multiple Imputation for Nonresponse in Surveys. Wiley & Sons, 1987.
26Frew, E. Applied Methods of Cost-Benefit Analysis in Health Care. Oxford University Press, 2010.
27Lejtzen, N, Sundquist, J, Sundquist, K, Li, X. Depression and anxiety in Swedish primary health care: prevalence, incidence, and risk factors. Eur Arch Psychiatry Clin Neurosci 2014; 264: 235–45.
28Piet, J, Hougaard, E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev 2011; 31: 1032–40.
29Edwards, RT, Bryning, L, Crane, R. Design of economic evaluations of mindfulness-based interventions: ten methodological questions of which to be mindful. Mindfulness 2015; 6: 490500.
30Briggs, A. Economic evaluation and clinical trials: size matters. BMJ 2000; 321: 1362–3.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary materials

Saha et al. supplementary material
Saha et al. supplementary material 1

 Word (5.6 MB)
5.6 MB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Economic evaluation of mindfulness group therapy for patients with depression, anxiety, stress and adjustment disorders compared with treatment as usual

  • Sanjib Saha (a1), Johan Jarl (a2), Ulf-G Gerdtham (a3), Kristina Sundquist (a4) and Jan Sundquist (a4)...
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *